Rosacea
Conditions
Interventions
SKE-18, vehicle, and white petrolatum are applied.
Sponsors
Kasumi Sanpei
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: 1. Healthy Japanese adult males aged 18 to 40 years at the time of signing the Informed Consent Form 2. Subjects with BMI (body mass index) of >= 18.5 to < 25.0 at screening 3. Subjects who are considered by the investigator as acceptable for inclusion in the study as judged from the results of observation and inspection upon screening and admission 4. Subjects who received full explanations regarding the objective of the study, details of the study and the study drug and provided voluntary written informed consent
Exclusion criteria
Exclusion criteria: 1. Subject with a medical history of drug allergy 2. Subjects with a medical history of food allergy 3. Subjects with a medical history (heart, liver, kidney, lung, blood diseases, etc.) that is considered ineligible for the study 4. Subjects with a medical history of contact dermatitis, such as adhesive tape dermatitis, or mechanical urticaria 5. Subjects with a medical history of photosensitivity 6. Subjects considered ineligible for the study by the investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Safety | — |
Contacts
Public ContactClinical Trials Information Desk
Sato Pharmaceutical Co., Ltd.
Outcome results
None listed